Christophe Kolahi

Christophe Kolahi currently holds the role of Business Development & Licensing Manager at PHARNEXT, overseeing the out licensing process of PXT3003 for Charcot-Marie-Tooth disease type 1A. Prior to this, Christophe has held various roles in commercial excellence, corporate strategy, and technology transfer in companies like Baxter International Inc., Mundipharma International Limited, and SATT idfinnov. With a background in biopharmaceutical management and chemical engineering, Christophe's expertise lies in analyzing and identifying business opportunities within the healthcare sector.